We play an active role in breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.

Our team produces media releases, reports, policy papers and other forms of informative content to keep stakeholders up to date on the most pressing issues facing our industry. Here in our resources section, you’ll be able to find our most recent work.

Cost Drivers Analysis of Private Drug Plans in Canada 2016-2018 Cost Drivers Analysis of Private Drug Plans in Canada 2016-2018 Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans (March 2019) Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans (March 2019) Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications (February 2019) Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications (February 2019) EY Report: An assessment of Canada’s current and potential future attractiveness as a launch destination for innovative medicines (January 2019) EY Report: An assessment of Canada’s current and potential future attractiveness as a launch destination for innovative medicines (January 2019) 2018 Annual Report 2018 Annual Report Real World Evidence Workshop: Industry Input – IMC/BIOTECanada Working Group (2018) Real World Evidence Workshop: Industry Input – IMC/BIOTECanada Working Group (2018) Guide to Providing Clinician Input and Feedback with the pCODR Program (2018) Guide to Providing Clinician Input and Feedback with the pCODR Program (2018) Value Demonstration with Private Payers Adherence to Treatment & Employer Economic Impact: Literature Review (2018) Value Demonstration with Private Payers Adherence to Treatment & Employer Economic Impact: Literature Review (2018) Private Drug Plan Drug Cost Forecast (2017-2019) Private Drug Plan Drug Cost Forecast (2017-2019) Cost Drivers Analysis of Private Drug Plans in Canada 2012-2016 Cost Drivers Analysis of Private Drug Plans in Canada 2012-2016 Understanding the Gap: A Pan-Canadian Analysis of Prescription Drug Insurance Coverage Understanding the Gap: A Pan-Canadian Analysis of Prescription Drug Insurance Coverage 2017 Annual Report 2017 Annual Report Nanos: Prescription Use Survey Summary Nanos: Prescription Use Survey Summary Data Analytics and Members’ Economic Footprint and Impact in Canada Data Analytics and Members’ Economic Footprint and Impact in Canada Private Drug Plan Drug Cost Forecast (2016-2018) Private Drug Plan Drug Cost Forecast (2016-2018) Making Canada Better 2017 - Conference Summary Report Making Canada Better 2017 - Conference Summary Report 2016 Annual Report 2016 Annual Report Access to New Medicines in Public Drug Plans: Canada and Comparable Countries - 2016 Annual Report Access to New Medicines in Public Drug Plans: Canada and Comparable Countries - 2016 Annual Report